Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: Apr 11, 2025

Total Value ($000): $437,696 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 65.6%

Value ($000) $287,070 Shares 19,963,157 Est. Cost $20.88 Unrealized —

NAMS NEWAMSTERDAM PHARMA COMPANY 13.4%

Value ($000) $58,740 Shares 2,869,565 Est. Cost $10.96 Unrealized +102.9%

PHAT PHATHOM PHARMACEUTICALS INC 10.7%

Value ($000) $46,803 Shares 7,464,572 Est. Cost $13.72 Unrealized -55.7%

— RAPT THERAPEUTICS INC 6.2%

Value ($000) $27,269 Shares 22,352,000 Est. Cost $1.58 Unrealized —

AURA AURA BIOSCIENCES INC 4.1%

Value ($000) $17,814 Shares 3,039,892 Est. Cost $17.87 Unrealized -57.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$287,070	65.6%	$20.88	—	SPONSORED ADS	152309100
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$58,740	13.4%	$10.96	+102.9%	ORDINARY SHARES	N62509109
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$46,803	10.7%	$13.72	-55.7%	COM	71722W107
—	RAPT THERAPEUTICS INC	22,352,000	$27,269	6.2%	$1.58	—	COM	75382E109
AURA	AURA BIOSCIENCES INC	3,039,892	$17,814	4.1%	$17.87	-57.7%	COM	05153U107